Islet Holdings, Inc.
Islet Holdings, Inc.
Your view on ISHI
Overview
What the company does, where it operates, and who runs it.
About Islet Holdings, Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- J. Michael Heil
- Headquarters
- 11884 Tammy Way, Grass Valley, CA, US
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- J. Michael Heil
- Headquarters
- 11884 Tammy Way, Grass Valley, CA, US
Islet Holdings, Inc. offers skincare products in the United States. It provides acne-prone skin products, anti-aging products, berridroxies, botanical products, eye treatments, moisturizers and creams, sensitive skin products, toners and cleansers, and specialized products. The company also distributes skincare products of various other brands.
It offers products online. Islet Holdings, Inc. was formerly known as Biozhem Cosmeceuticals, Inc. and changed its name to Islet Holdings, Inc. in May 2009. The company was incorporated in 1984 and is based in Grass Valley, California. It has a customer service center in Arizona.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Islet Holdings, Inc., and the rating behind it. ISHI last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Islet Holdings, Inc.. Starting points for Islet Holdings, Inc.: EPS -$96.40, beta 1.00 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Islet Holdings, Inc.. Islet Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Islet Holdings, Inc.. Trailing twelve-month EPS for Islet Holdings, Inc. stands at -$96.40. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Islet Holdings, Inc.. Islet Holdings, Inc. has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Islet Holdings, Inc. valued side by side against its closest peers. Islet Holdings, Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Islet Holdings, Inc., and how their positions are changing. At a $5 market value, institutional positions materially move Islet Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Islet Holdings, Inc. executives and directors. Shares of Islet Holdings, Inc. have traded between $0.0001 and $0.0002 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Islet Holdings, Inc.. Islet Holdings, Inc. is a $5 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Islet Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Islet Holdings, Inc.. Coverage tracks Islet Holdings, Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.